Literature DB >> 19925924

Angiogenesis in cutaneous disease: part I.

Amy Nguyen1, Van Hoang, Vivian Laquer, Kristen M Kelly.   

Abstract

UNLABELLED: Angiogenesis is an important process in normal physiology and disease pathogenesis. Angiogenesis is controlled in a healthy body by a system of angiogenic growth factors and angiogenesis inhibitors. When angiogenic growth factors are predominantly expressed, blood vessel growth occurs and disease may result. Successful therapies have been developed that target growth factors, their receptors, or the cascade pathways that are activated by growth factor/receptor interactions. There is good evidence that angiogenesis plays an important role in a wide range of cutaneous maladies, and angiogenesis-targeting therapies are playing an increasing role in the management of dermatologic disease. Cutaneous angiogenesis offers an exciting new arena for targeted dermatologic therapeutics. LEARNING
OBJECTIVES: After completing this learning activity, participants should be able to distinguish angiogenic growth factors and inhibitors, recognize angiogenic mediating agents and compare their mechanisms of action, and apply the use of angiogenic mediating agents in clinical and research situations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925924     DOI: 10.1016/j.jaad.2009.05.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

Review 1.  Novel antiangiogenic agents in dermatology.

Authors:  Ricardo L Berrios; Jack L Arbiser
Journal:  Arch Biochem Biophys       Date:  2010-12-21       Impact factor: 4.013

2.  Immunohistochemistry of angiogenesis mediators before and after pulsed dye laser treatment of angiomas.

Authors:  Vivian T Laquer; Belinda M Dao; Janelle M Pavlis; Amy N Nguyen; Tina S Chen; Ronald M Harris; Elizabeth L Rugg; Kristen M Kelly
Journal:  Lasers Surg Med       Date:  2012-02-02       Impact factor: 4.025

Review 3.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

4.  Successful Treatment of Unilateral Klippel-Trenaunay Syndrome With Pulsed-Dye Laser in a 2-Week Old Infant.

Authors:  Hoda Rahimi; Habib Hassannejad; Hamideh Moravvej
Journal:  J Lasers Med Sci       Date:  2017-03-28

5.  Microarray analysis of port wine stains before and after pulsed dye laser treatment.

Authors:  Vivian T Laquer; Peter A Hevezi; Huguette Albrecht; Tina S Chen; Albert Zlotnik; Kristen M Kelly
Journal:  Lasers Surg Med       Date:  2013-02       Impact factor: 4.025

6.  Cloning and expression of human vascular endothelial growth factor gene and inhibition of its expression by antisense in prokaryotic system.

Authors:  M Yazdanfar; M Bandehpour; F Yarian; A Koochaki; K Parivar; B Kazemi
Journal:  Daru       Date:  2010       Impact factor: 3.117

7.  Inhibition of Angiogenesis: A Novel Effect of Zataria Multiflora.

Authors:  Amir Hossein Norooznezhad; Maryam Keshavarz; Fatemeh Norooznezhad; Kamran Mansouri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

8.  Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein.

Authors:  Hossein Heydar; Kamran Mansouri; Maryam Norooznezhad; Fatemeh Norooznezhad; Abdolreza Mohamadnia; Naghmeh Bahrami
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-04-01

Review 9.  Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses.

Authors:  Dehai Xian; Jing Song; Lingyu Yang; Xia Xiong; Rui Lai; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2019-04-16       Impact factor: 6.543

10.  Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.

Authors:  Jihyun Lee; Yujin Jung; Seo Won Jeong; Ga Hee Jeong; Gue Tae Moon; Miri Kim
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.